Tzeng DTW - Search Results

1

4-Acetyl-Antroquinonol B Suppresses SOD2-Enhanced Cancer Stem Cell-Like Phenotypes and Chemoresistance of Colorectal Cancer Cells by Inducing hsa-miR-324 re-Expression.

Bamodu OA, Yang CK, Cheng WH, Tzeng DTW, Kuo KT, Huang CC, Deng L, Hsiao M, Lee WH, Yeh CT. Bamodu OA, et al. Among authors: tzeng dtw. Cancers (Basel). 2018 Aug 10;10(8):269. doi: 10.3390/cancers10080269. Cancers (Basel). 2018. PMID: 30103475 Free PMC article.

2

A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.

Yeh CT, Huang WC, Rao YK, Ye M, Lee WH, Wang LS, Tzeng DT, Wu CH, Shieh YS, Huang CY, Chen YJ, Hsiao M, Wu AT, Yang Z, Tzeng YM. Yeh CT, et al. Carcinogenesis. 2013 Dec;34(12):2918-28. doi: 10.1093/carcin/bgt255. Epub 2013 Jul 23. Carcinogenesis. 2013. PMID: 23880305

3

Destruxin B inhibits hepatocellular carcinoma cell growth through modulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.

Huynh TT, Rao YK, Lee WH, Chen HA, Le TD, Tzeng DT, Wang LS, Wu AT, Lin YF, Tzeng YM, Yeh CT. Huynh TT, et al. Toxicol In Vitro. 2014 Jun;28(4):552-61. doi: 10.1016/j.tiv.2014.01.002. Epub 2014 Jan 13. Toxicol In Vitro. 2014. PMID: 24434019

4

Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity.

Bamodu OA, Huang WC, Tzeng DT, Wu A, Wang LS, Yeh CT, Chao TY. Bamodu OA, et al. Cancer Lett. 2015 Aug 10;364(2):125-34. doi: 10.1016/j.canlet.2015.05.006. Epub 2015 May 11. Cancer Lett. 2015. PMID: 25976769

5

Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways.

Chen YA, Tzeng DTW, Huang YP, Lin CJ, Lo UG, Wu CL, Lin H, Hsieh JT, Tang CH, Lai CH. Chen YA, et al. Among authors: tzeng dtw. Cancers (Basel). 2018 Dec 31;11(1):34. doi: 10.3390/cancers11010034. Cancers (Basel). 2018. PMID: 30602706 Free PMC article.

6

Ovatodiolide, isolated from Anisomeles indica, suppresses bladder carcinogenesis through suppression of mTOR/β-catenin/CDK6 and exosomal miR-21 derived from M2 tumor-associated macrophages.

Wu ATH, Srivastava P, Yadav VK, Tzeng DTW, Iamsaard S, Su EC, Hsiao M, Liu MC. Wu ATH, et al. Among authors: tzeng dtw. Toxicol Appl Pharmacol. 2020 Aug 15;401:115109. doi: 10.1016/j.taap.2020.115109. Epub 2020 Jun 13. Toxicol Appl Pharmacol. 2020. PMID: 32544403

7

Identification of Cancer Hub Gene Signatures Associated with Immune-Suppressive Tumor Microenvironment and Ovatodiolide as a Potential Cancer Immunotherapeutic Agent.

Chen JH, Wu ATH, Lawal B, Tzeng DTW, Lee JC, Ho CL, Chao TY. Chen JH, et al. Among authors: tzeng dtw. Cancers (Basel). 2021 Jul 30;13(15):3847. doi: 10.3390/cancers13153847. Cancers (Basel). 2021. PMID: 34359748 Free PMC article.

8

Ovatodiolide and antrocin synergistically inhibit the stemness and metastatic potential of hepatocellular carcinoma via impairing ribosome biogenesis and modulating ERK/Akt-mTOR signaling axis.

Chen MY, Hsu CH, Setiawan SA, Tzeng DTW, Ma HP, Ong JR, Chu YC, Hsieh MS, Wu ATH, Tzeng YM, Yeh CT. Chen MY, et al. Among authors: tzeng dtw. Phytomedicine. 2023 Jan;108:154478. doi: 10.1016/j.phymed.2022.154478. Epub 2022 Sep 25. Phytomedicine. 2023. PMID: 36265255

9

Therapeutic targeting of hepatocellular carcinoma cells with antrocinol, a novel, dual-specificity, small-molecule inhibitor of the KRAS and ERK oncogenic signaling pathways.

Hsu CH, Weng PW, Chen MY, Yeh CT, Setiawan SA, Yadav VK, Wu ATH, Tzeng DTW, Gong JX, Yang Z, Tzeng YM. Hsu CH, et al. Among authors: tzeng dtw. Chem Biol Interact. 2023 Jan 25;370:110329. doi: 10.1016/j.cbi.2022.110329. Epub 2022 Dec 22. Chem Biol Interact. 2023. PMID: 36565974

10

Preclinical investigation of ovatodiolide as a potential inhibitor of colon cancer stem cells via downregulating sphere-derived exosomal β-catenin/STAT3/miR-1246 cargoes.

Huang YJ, Huang TH, Yadav VK, Sumitra MR, Tzeng DT, Wei PL, Shih JW, Wu AT. Huang YJ, et al. Am J Cancer Res. 2020 Aug 1;10(8):2337-2354. eCollection 2020. Am J Cancer Res. 2020. PMID: 32905416 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters